Flashpoint VC

Flashpoint VC is a multi-strategy venture firm with European and Israeli roots, running funds across venture capital, venture debt, and growth stages with a generalist B2B software focus. The flashpointvc.com website and LinkedIn presence indicate an active multi-fund platform with portfolio diversity across enterprise SaaS, fintech, and selective vertical applications. For healthcare AI founders, Flashpoint is a generalist B2B investor without a defined healthcare practice; relevance depends on whether your business is fundamentally a horizontal B2B SaaS play with strong unit economics rather than a clinical or regulated business. Plausible check sizes vary by fund: venture vehicles likely write 1M to 5M at Series A, with the venture debt arm capable of larger debt facilities for revenue-stage businesses. Founders building healthcare workflow SaaS, AI productivity tools sold into healthcare buyers, or revenue-stage healthcare software seeking debt to extend runway should approach. Founders building clinical AI, medtech, biotech, or anything requiring deep healthcare regulatory expertise should look at healthcare-native firms instead. Entry path is LinkedIn outreach to partners across the European and Israeli offices, or warm introduction through B2B SaaS founders in their portfolio. Diligence will lean heavily on metrics: ARR growth, net dollar retention, CAC payback, gross margins. The healthcare lens will be light; expect to be evaluated as a B2B SaaS company first, with healthcare specifics treated as market context rather than core risk. The venture debt option is genuinely useful for capital-efficient teams looking to avoid dilution, and that may be the most differentiated offering Flashpoint has for the right founder.